1 |
CC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery – executive summary. Circulation. 2002; 105: 1257-1267. |
2 |
Poldermans D, Bax JJ, Kertai MD et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation. 2003; 107: 1848-51. |
3 |
Durazzo AE, Machado FS, Ikeoka DT et al. Reduction in cardiovascular events after vascular surgery with atorvastatin. J.Vasc. Surg. 2004; 39: 967-75. |
4 |
Lindenauer PK, Pekow P, Wang K, Gutierrez B, Benjamin EM. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 2004; 291: 2092-9. |
5 |
McFalls EO, Ward HB, Moritz TE et al. Coronary-artery revascularization before elective major vascular surgery. N.Engl.J.Med. 2004; 351: 2795-804. |
6 |
http://www.vasgbi.com/constitn.htm |
7 |
Guidelines for the use of platelet transfusions. British Committee for Standards in Haematology. British Journal of Haematology. 2003, 122: 10-23. |
8 |
Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. British Committee for Standards in Haematology. http://www.bcshguidelines.com/pdf/freshfrozen_280604.pdf |
9 |
Practice guidelines for blood component therapy. American Society of Anesthesiologists. http://www.asahq.org/publicationsAndServices/blood_component.html |
10 |
National Confidential Enquiry into Patient Outcome and Death. Scoping our practice? 2004. |
11 |
National Confidential Enquiry into Patient Outcome and Death. An Acute Problem? 2005. |